Ultracompact R-PCR System Reaches the American Biotech Market

Biotech and other life science researchers in the United States will soon be able to outfit their laboratories with a new state-of-the-art ultracompact real-time PCR (R-PCR) system.

Roche (Basel, Switzerland), the world's largest biotech company, will begin marketing the LightCycler Nano real-time PCR system in the US in November 2011.


This compact instrument shares the state-of-the-art technology of the LightCycler portfolio, producing high quality data in qPCR (quantitative R-PCR), genotyping, and high resolution melting on a small platform. The system employs innovative optics and thermal control to provide an extremely low variation of well-to-well performance.

With its 32-well format, the LightCycler Nano is able to fit comfortably on the benchtop. Its easy-to-use software is compatible with both Macintosh and Windows-PC operating systems.

"Many research labs use 96-well instruments, but the average number of samples per run is often below the capacity of the instruments," said Brigitte Fernandes-McAlear, vice president of marketing at Roche. "This compact platform should satisfy the needs of many PCR researchers by fitting well into their work environment while delivering excellent results."

Related Links:
Roche